Abstract:Background: The monitoring and management of blood glucose concentration are standard practices in critical settings as hyperglycaemia has been shown close association with poorer outcomes. Several meta-analyses have revealed that intensive glucose control has no benefit in decreasing short-term mortality among critically ill patients, while the studies these meta-analyses have incorporated have been largely divergent. We aim to perform a more comprehensive meta-analysis addressing this problem to provide stronger evidence.Methods: We conducted comprehensive searches for relevant randomized controlled studies in online databases, including the Cochrane Library, EMBASE, and PubMed databases, up to September 1, 2018. The clinical data, which included all-cause mortality, severe hypoglycemia, need for RRT, infection resulting in sepsis, ICU mortality, 90-day mortality, 180-day mortality, and hospital and ICU lengths of stay, were screened and analyzed after data extraction. We applied odds ratios (ORs) to analyze dichotomous outcomes and mean differences for continuous outcomes with a random effects model.Results: A total of 57 RCTs involving a total of 21840 patients were finally included. Patients admitted to the ICU who underwent intensive glucose control showed significantly reduced all-cause mortality (OR: 0.89; 95% CI: 0.80-1.00; P=0.04; I2=32%), reduced infection rate (OR: 0.65, 95% CI: 0.51-0.82, P=0.0002; I2=47%), a lower occurrence of acquired sepsis (OR: 0.80, 95% CI: 0.65-0.99, P=0.04; I2=0%) and shortened length of ICU stay (MD: -0.70, 95% CI: -1.21--0.19, P=0.007, I2=70%) when compared to the same parameters as those treated with the usual care strategy. However, patients in the intensive glucose control group presented with a significantly higher risk of severe hypoglycemia (OR: 5.63, 95% CI: 4.02-7.87, P<0.00001; I2=67%).Conclusions: Critically ill patients undergoing intensive glucose control showed significantly reduced all-cause mortality, length of ICU stay and incidence of acquired infection and sepsis compared to the same parameters in patients treated with the usual care strategy, while the intensive glucose control strategy was associated with higher occurrence of severe hypoglycemic events.

The Management of Blood Glucose in ICU

Recent progress of hyperglycemia in critically ill patients

Target of Blood Glucose Control in the Critically Ill Patients: the Tighter, the Better?

Real-time Continuous Glucose Monitoring Versus Conventional Glucose Monitoring in Critically Ill Patients: a Systematic Review Study Protocol.

Blood sugar control in the intensive care unit: time to relook

Blood Glucose Control and Prognosis of Critical Ill Patients

Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis

Impact of Intensive Insulin Therapy on Surgical Critically Ill Patients

Impact of insulin therapy to control blood glucose on different levels on criticaly ill patients

Clinical Analysis of Inpatients with Hyperglycemia in the Medical Intensive Care Units——data of Shanghai Renji Hospital from 2002 to 2009

[The Effect of Blood Glucose Fluctuations on Prognosis of Critically Ill Patients in Intensive Care Unit].

Blood glucose control in the burn intensive care unit: A narrative review of literature

Intensive Versus Conventional Glucose Control In Critically Ill Patients: A Meta-Analysis Of Randomized Controlled Trials

Status quo and content analysis of relevant clinical practice guidelines of blood glucose management for critically ill adult patients

Optimal Target Range for Blood Glucose in Hyperglycaemic Patients in a Neurocritical Care Unit.

Accuracy of Blood Glucose Measurement and Blood Glucose Targets

Tight versus liberal blood-glucose control in the intensive care unit: special considerations for patients with diabetes

Hyperglycemia in critical illness: a review

Glycemic Management in Patients with COVID-19 Admitted to the Intensive Care Unit: Evaluation of Glycemic Control and Drug Therapy

Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting

Intensive Insulin Therapy on Stress Hyperglycemia in Critical Ill Patients